ARK Investment Management 13F, Q3 2023

Cathie Wood · quarter ending 30 September 2023 · filed 18 October 2023 · SEC CIK 1697748

$13.07B
Filed US book
225
Positions
7.8%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed.

Largest positions, Q3 2023

The 25 largest of 225 positions. Weights are against the whole filed book. Changes are in shares held, against the Q2 2023 filing.

CompanyTickerValue% of bookvs Q2 2023
Tesla IncTSLA$1.02B7.8%-16% shares
UiPath IncPATH$809.75M6.2%unchanged
Coinbase Global IncCOIN$796.12M6.1%-13% shares
Roku IncROKU$736.95M5.6%-13% shares
Zoom Video Communications IncZM$712.19M5.5%-3% shares
Block IncXYZ$481.86M3.7%unchanged
DraftKings IncDKNG$430.64M3.3%-19% shares
Exact Sciences CorpEXK$428.49M3.3%-12% shares
Twilio IncTWLO$417.44M3.2%unchanged
Shopify IncSHOP$379.54M2.9%-22% shares
Teladoc Health IncTDOC$377.60M2.9%unchanged
Unity Software IncU$360.27M2.8%-4% shares
ROBLOX CorpRBLX$346.76M2.6%+29% shares
Ginkgo Bioworks Holdings Inc$329.77M2.5%+7% shares
CRISPR Therapeutics AG$325.13M2.5%-2% shares
Robinhood Markets IncHOOD$322.11M2.5%+3% shares
Intellia Therapeutics IncNTLA$314.58M2.4%+4% shares
Pacific Biosciences of CaliforPACB$249.02M1.9%+12% shares
PagerDuty IncPD$237.37M1.8%unchanged
Beam Therapeutics IncBEAM$211.25M1.6%+5% shares
Veracyte IncVCYT$169.56M1.3%-3% shares
Palantir Technologies IncPLTR$150.78M1.1%+38% shares
Teradyne IncTER$142.94M1.1%+21% shares
Twist Bioscience CorpTWST$137.48M1.1%-3% shares
10X Genomics IncTXG$123.48M0.9%-4% shares

What changed since Q2 2023

Against the Q2 2023 filing, ARK Investment Management opened 13 new positions, added to 74, trimmed 112, left 26 unchanged and exited 9. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

  • CCJ$13.37M
  • AvidXchange Holdings Inc$9.55M
  • Nikon Corp$5.04M
  • XRAY$4.38M
  • APO$2.49M
  • Valens Semiconductor Ltd$2.20M
  • NEOGAMES SA$2.08M
  • Exco Technologies Ltd$1.78M

and 5 more

Exited

  • CDXSwas $11.55M
  • IOVAwas $5.46M
  • JDwas $3.91M
  • Arconic Corpwas $2.57M
  • Allot Ltdwas $2.22M
  • Aerojet Rocketdyne Holdings Inwas $2.10M
  • Surface Oncology Incwas $1.23M
  • PhenomeX Incwas $1.09M

and 1 more

Added to

  • RBLX+29%$346.76M
  • Ginkgo Bioworks Holdings Inc+7%$329.77M
  • HOOD+3%$322.11M
  • NTLA+4%$314.58M
  • PACB+12%$249.02M
  • BEAM+5%$211.25M
  • PLTR+38%$150.78M
  • TER+21%$142.94M

and 66 more

Trimmed

and 104 more

Other quarters

Source: SEC Form 13F-HR, accession 0001104659-23-109811, filed by ARK Investment Management LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.